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Neuronal homeostasis depends on the proper functioning of different quality control
systems. All intracellular components are subjected to continuous turnover through
the coordinated synthesis, degradation and recycling of their constituent elements.
Autophagy is the catabolic mechanism by which intracellular cytosolic components,
including proteins, organelles, aggregates and any other intracellular materials, are
delivered to lysosomes for degradation. Among the different types of selective
autophagy described to date, the process of mitophagy involves the selective
autophagic degradation of mitochondria. In this way, mitophagy is responsible for
basal mitochondrial turnover, but can also be induced under certain physiological or
pathogenic conditions to eliminate unwanted or damaged mitochondria. Dysfunctional
cellular proteolytic systems have been linked extensively to neurodegenerative diseases
(ND) like Alzheimer’s disease (AD), Parkinson’s disease (PD), or Huntington’s disease
(HD), with autophagic failure being one of the main factors contributing to neuronal cell
death in these diseases. Neurons are particularly vulnerable to autophagic impairment
as well as to mitochondrial dysfunction, due mostly to their particular high energy
dependence and to their post-mitotic nature. The accurate and proper degradation
of dysfunctional mitochondria by mitophagy is essential for maintaining control over
mitochondrial quality and quantity in neurons. In this report, I will review the role of
mitophagy in neuronal homeostasis and the consequences of its dysfunction in ND.
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MITOCHONDRIA AND PROTEIN QUALITY CONTROL IN
NEURONS
Although the origin, progression and heterogeneity of neurodegenerative diseases (ND) differs,
these disorders are characterized by common features at the molecular level. These include:
(i) accumulation of aggregated misfolded proteins; (ii) impairment of degradative processes
including autophagy and the ubiquitin proteasome system (UPS); (iii) oxidative stress;
(iv) neuroinflammation; and (v) impaired mitochondrial function comprising mitochondrial
dynamics, trafficking and turnover. In this review article, we focus attention on the last-mentioned
feature, particularly with respect to impaired mitochondrial degradation by autophagy (mitophagy)
in ND.
Due to their metabolic features and post-mitotic state, neurons are particularly vulnerable
to mitochondrial dysfunction and to deregulation of the proteostasis system. Mitochondria
are the main source of cellular energy, but also have other important cellular functions such
as control of programmed cell death, regulation of calcium homeostasis and the biosynthesis
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of protein cofactors such as heme and iron–sulfur clusters
(Nagley et al., 2010; Gleichmann andMattson, 2011; Stehling and
Lill, 2013). Mitochondria form a dynamic network controlled
by a range of cellular mechanisms to guarantee an appropriate
population of healthy mitochondria for each condition. This
mitochondrial network is regulated by the balance between
different highly regulated processes: mitochondrial dynamics
that control the division (fission) and fusion of mitochondria,
de novo mitochondrial biogenesis, and the elimination of
unwanted mitochondria by mitophagy (Ploumi et al., 2017).
Maintaining properly this healthy mitochondrial pool is
necessary for cellular homeostasis, but is particularly important
for neuronal viability. Neurons have a high energy requirement
that is dependent on mitochondrial metabolism as the main
energy source. As such, the mitochondrial network needs to
be in perfect working order. Moreover, the unique morphology
of neurons, with their axons and dendrites, means that
mitochondria must be recruited to distant parts of the cell
via axonal transport to satisfy energy demands at those sites.
Consequently, neurons are vulnerable to defects in axonal
trafficking. Finally, due to the post-mitotic state of neurons,
cellular division cannot act as a diluting factor for components
accumulating within the cell: this means that neurons require
an adequate ‘‘cleaning system’’ to eliminate any damaged or
unwanted mitochondria that could be a source of reactive
oxygen species (ROS) or an inducer of programmed cell death.
Given their essential role in neuronal viability, any alterations
in mitochondrial function could lead to neuronal death, thus
explaining why mitochondrial dysfunction has been linked to
numerous ND.
Autophagy, or more precisely macroautophagy to
differentiate it from other forms of autophagy such as
chaperone-mediated autophagy (CMA) and microautophagy
(Martinez-Vicente, 2015), is the process whereby intracytosolic
components, including proteins and/or organelles, are delivered
to lysosomes to be degraded (Figure 1). The substrates of
this pathway are engulfed inside a double membrane vesicle
called autophagosome; once this vesicle is formed and loaded
with the substrates to be eliminated, it fuses with a lysosome,
a small single-membrane organelle that contains within its
matrix many types of degradative hydrolases that can digest
the macromolecules into their constitutive components. These
components can be reused to build new macromolecules.
Autophagy is one of the main mechanism that maintains cellular
homeostasis since it is responsible for: (i) the major part of
the basal turnover of intracellular material, thus preserving
the proper balance between synthesis and degradation; and
(ii) a quality control system capable of eliminating defective
and/or damaged proteins/organelles generated inside the cell. In
addition to autophagy, the cell also contains other intracellular
degradative systems as part of its protein quality control system;
these alternative mechanisms, working simultaneously and in a
coordinated manner with (macro)autophagy, are the UPS and
CMA. Whereas the latter systems can only eliminate selected
soluble cytosolic proteins, macroautophagy is the only process
that can also degrade whole organelles and as well as aggregated
proteins. This feature is extremely important, contributing to
the essential role of (macro)autophagy in neuron health and
survival (Martinez-Vicente, 2015). As mentioned above, neurons
are especially vulnerable to any impairment of the degradative
systems. To this end, in 2006 the Mizushima and Tanaka
groups showed that an active basal autophagy is essential for
neuronal viability, as its inactivation leads to the intracytosolic
accumulation of protein aggregates and damaged organelles and
finally to neuronal cell death (Hara et al., 2006; Komatsu et al.,
2006).
In addition to these degradative systems of intracellular
components, the endosomal-lysosomal system also contribute
to the degradation inside the lysosomes of different types of
macromolecules, these substrates provided by endosomes are
commonly extracellular components internalized into the cell by
endocytosis (Figure 1).
It is possible to differentiate between basal autophagy, which
is responsible for the continuous turnover of intracellular
components, and induced autophagy, a stress-response
mechanism activated under different conditions to provide
essential basic elements like amino acids, to remove damaged
proteins or organelles, or to eliminate external pathogens. Thus,
induced autophagy can be activated in response to starvation,
exposure to oxidative stress, hypoxia, mitochondrial damage,
and many other conditions where specific materials must
be eliminated from the cell. In fact, autophagy can randomly
sequester and eliminate portions of the cytosol with whatever that
may contain, in addition to being a selective process to eliminate
specific substrates like mitochondria, endoplasmic reticulum
(ER), ribosomes, pathogens, lipid droplets, peroxisomes and
aggregates (Dunn et al., 2005; Levine, 2005; Bernales et al., 2007;
Kim et al., 2007; Kraft et al., 2008; Singh et al., 2009; Yamamoto
and Simonsen, 2011) (Figure 1). Although all these types of
selective autophagy might be activated by different signals, all
such cases follow a similar pattern and require an autophagic
receptor, this being a protein that plays a connective role between
the substrate and the newly formed or nascent autophagosome.
MITOPHAGY
Among the different types of selective autophagy, mitophagy
is the field where most research progress has been made in
recent times. Over the last decade, knowledge of the molecular
mechanisms underlying this process, as well as the proteins and
molecules involved, and their role under normal and pathologic
conditions has increased greatly.
Mitophagy is the only known pathway via which whole
mitochondria can be selectively eliminated. This mechanism was
first characterized in yeast in 2004 (Kissová et al., 2004). Later,
in 2006, the term ‘‘mitophagy’’ was used by Lemaster’s group
in relation to mammalian cells; they showed that depolarized
mitochondria localize inside light chain 3 (LC3)-GFP-labeled
autophagosomes before being completely degraded (Rodriguez-
Enriquez et al., 2006).
Mitophagy is responsible for the basal mitochondrial
turnover that eliminates old mitochondria once they are
no longer needed; however, mitophagy can also be induced
under certain physiological conditions, examples of which
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FIGURE 1 | Autophagy and endocytosis can delivery substrates to lysosome for degradation. Autophagy is a tightly regulated process by which certain
intracellular components are recycled through lysosomal degradation. Various types of autophagy are present in mammalian cells: microautophagy involves the
sequestration and degradation of complete regions of the through invaginations of the lysosomal membrane. Macroautophagy (commonly referred as “autophagy”)
consists in the engulfment of intracellular components in a double membrane vesicle called autophagosome. This vesicle is then fused with lysosomes to form an
autophagoslysosome and the lysosomal hydrolytic enzymes complete the degradation. Under some conditions, macroautophagy can be a selective mechanism
where specific substrates are recognized by distinct autophagic receptors and eliminated. Among the different types of selective (macro)autophagy, mitophgay
consists in selective degradation of mitochondria. Chaperone-mediated autophagy (CMA) is a proteolytic pathway where specific cytosolic proteins containing a
CMA-motif are recognized by chaperones and directly translocated into the lysosome through the CMA receptor formed by LAMP-2A protein. Extracellular
components can also be degraded by endocytosis when late endosome fuse with lysosomes or alternatively, first with an autophagosomes and later on with a
lysosome. Intracellular proteins can also be degraded by the ubquitin proteasomal system (UPS). All degradative pathways work coordinated and simultaneously to
maintain cellular homeostasis.
are the maturation of erythrocytes, where mitochondria and
other organelles must be removed from the cell, and the
development of fertilized oocytes, when paternal mitochondria
must be removed (Sandoval et al., 2008; Sato and Sato, 2011).
In addition to these physiological roles, mitophagy can be
induced as a stress-response mechanism to eliminate selectively
damaged mitochondria after depolarization of the mitochondrial
membrane or in response to hypoxia. As such, several types of
mitophagy have been described, corresponding to the different
ways that mitochondria are engulfed within an autophagosome
prior to being delivered to a lysosome for completion of the
degradation process.
All types of mitophagy follow a general pattern involving a
receptor-mediated mechanism whereby the receptors physically
connect the mitochondria to be eliminated with LC3-II, the main
component of the autophagosomal membrane. This connection
is established via the LC3-interacting region (LIR) present in all
receptors (Wild et al., 2014). The nature and origin of mitophagy
receptors can vary depending on the type of mitophagy; some
receptors are proteins or lipids localized in the mitochondrial
membrane, while others are non-mitochondrial proteins that
recognize and simultaneously bind ubiquitinated chains on the
mitochondrial surface and LC3-II on the nascent autophagosome
structure. These receptors contain both the LIR motif to bind
LC3, and the ubiquitin binding domain (UBD) to bind ubiquitin
(UB) chains on the targeted mitochondria (Wild et al., 2014).
Mitophagy Mediated by Mitochondrial
Membrane Receptors
Proteins in the outer mitochondrial membrane (OMM),
such as B-cell lymphoma 2 nineteen kilodalton interacting
protein 3 (BNIP3), Nix, Bcl-2-like protein 13 (Bcl2-L-13) and
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FUND1, can act as mitophagy receptors under specific
conditions and in certain cell types. All of these proteins
contain the LIR motif to facilitate direct interaction of
the mitochondria with LC3 or other LC3/GABARAP family
members in order to recruit the autophagosomal machinery
(Figure 2).
BNIP3 and its analog Nix (also called BNIP3L) belong to
the Bcl-2 family and are BH3-only pro-apoptotic proteins. They
were initially described as proteins involved in programmed cell
death, but later were also shown to act as mitophagy receptors
(Zhang and Ney, 2009). Nix was first described as a mitophagy
receptor during reticulocyte maturation when mitochondria are
eliminated from the erythrocyte (Schweers et al., 2007; Sandoval
et al., 2008). BNIP3 and NIX can be regulated by hypoxia,
with hypoxia-inducible factor-1 (HIF-1) being a transcriptional
factor that activates BNIP3 and NIX expression in response
to low oxygen levels. More recently, however, it was shown
that these receptors might also be regulated post-translationally
by phosphorylation via an as-yet unknown mechanism (Zhu
et al., 2013). Another BCL-2 family member, called Bcl2-L-13,
was recently described, this protein is the mammalian homolog
of Atg32, the first mitophagy receptor described in yeast in
2009, this protein can mediate both mitochondrial clearance by
mitophagy and also mitochondrial fragmentation (Murakawa
et al., 2015).
FUND1 is another OMM protein that is also activated
in response to hypoxia; its activity is regulated by several
reversible phosphorylations mediated by different kinases and
phosphatases, including ULK1 (Liu L. et al., 2012; Wu et al.,
2016).
AMBRA1 is a multifunctional protein that can act as a
sensor to coordinate the cell response to different stressors;
its involvement has been described in development, cell
proliferation, cell death and autophagy. AMBRA1 can operate
as a scaffold protein that regulates the stability of some
autophagy-related complexes such as mTOR complex 1 and
the ULK1 complex, and can also be partially localized to the
mitochondria where it can act as a mitophagy receptor by
binding directly to LC3 via its LIR motif (Cianfanelli et al., 2015;
Strappazzon et al., 2015).
In 2017, unexpectedly an inner membrane mitochondrial
protein has been described as mitophagy receptor. Prohibitin 2
(PHB2) is an inner mitochondrial membrane (IMM)
protein that can bind LC3-II through its LIR motif upon
mitochondrial depolarization and during the clearance of
paternal mitochondria after embryonic fertilization. In both
cases, rupture or partial degradation of the OMM mediated by
the proteasome is required to expose the inner protein PHB2 to
LC3 and the preautophagosome structure (Wei et al., 2017)
(Figure 2).
Cardiolipin-Mediated Mitophagy
Cardiolipin (CL) is a mitochondrial phospholipid present mostly
in the IMM. As a component of the mitochondrial membrane,
this compound regulates the stability of many mitochondrial
membrane protein complexes, like the respiratory chain or
the import machineries. It can also modulate other important
functions, like mitochondrial dynamics and the induction of
apoptosis by regulating the localization of cytochrome c at the
IMM (Maguire et al., 2017). Despite being a phospholipid, it
also contains an LC3-binding motif and can directly bind the
N-terminal domain of LC3-II (Chu et al., 2013). When CL is
externalized from the inner to the OMM, it can function as
a mitophagy receptor to recruit LC3 and the autophagosome
machinery; in this case no protein is involved, the interaction
is done directly between CL and LC3-II. The regulation of the
externalization of CL is mediated by several proteins (Maguire
et al., 2017) and is activated in response to depolarization.
Non-Mitochondrial Receptors (p62,
NDP52, OPTN, NBR1, TAX1BP1) and
PINK1/Parkin-Mediated Mitophagy
Mitophagy receptors can also be cytosolic proteins that
recognize both the target mitochondria and the autophagosome.
Mitochondria are recognized by two domains present in these
receptors: the UBD that binds to polyubiquitinated OMM
proteins on the mitochondrial surface, and the LIR motif that
binds LC3-II present on the autophagosome structure (Wild
et al., 2014).
The most appealing and most studied mechanism of this
pathway involves how mitochondria are selectively tagged
by post-translational modification (phosphorylated-ubiquitin,
P-UB chains) for subsequent elimination. In this mechanism,
two main proteins, the PTEN-induced putative kinase 1
(PINK1) and Parkin, are involved. This type of mitophagy
is known as PINK1/Parkin-mediated mitophagy and several
groups have contributed to the elucidation of the complex
molecular mechanisms by which these two proteins mediate
mitophagy in mammalian cells in response to mitochondrial
depolarization.
PINK1 has a role as mitochondrial stress sensor; the protein
is imported from the cytosol to mitochondria under basal
conditions, following which translocase complexes TOM and
TIM drive the transport of PINK1 from the OMM to the IMM in
a mitochondrial transmembrane potential-dependent manner.
Once PINK1 reaches the IMM, it is cleaved by mitochondrial
matrix proteases such as mitochondrial processing peptidase
(MPP) and presenilin-associated rhomboid-like protease
(PARL), with the resulting cleaved protein externalized to the
cytosol where it is degraded by the UPS (Jin et al., 2010; Deas
et al., 2011; Greene et al., 2012; Yamano and Youle, 2013;
Meissner et al., 2015). When damaged mitochondria lose their
membrane potential, PINK1 processing is not complete and so
full-length PINK1 accumulates in the OMM in association with
the TOM complex. This is the first step to trigger the mitophagy
of dysfunctional mitochondria (Figure 2).
Once full-length PINK1 is present in the OMM, it can
phosphorylates UB at its serine65 tagged to OMM proteins.
The presence of P-UB in the OMM stimulates the recruitment
and activation of Parkin to damaged mitochondria given
Parkin’s high affinity for P-UB. Once at the mitochondrial
surface, Parkin is activated by PINK1 kinase activity through
the phosphorylation of its serine65. This active Parkin, as an
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FIGURE 2 | Mitochondrial degradation. Whole mitochondria can be degraded by mitophagy (upper panels) under different physiological and stress-induced
situations. Different mitophagy receptors link the mitochondria with the pre-autophagosome structure (PAS) through the direct intercation with light chain 3 (LC3)-II (in
purple). These receptor can be mitochondrial components (A) o non-mitochondrial proteins (B) that bind both the phosphorylated ubiquitin (P-UB) chains on the
mitochondria surface and LC3-II. Mitochondria can also be partially degraded (lower panel) through the formation of mitochondrial-derived vesicles (MDVs) that can
directly be fused with lysosomes (C). Some outer mitochondrial membrane (OMM) proteins can be degraded by the UPS (D) after mitochondrial depolarization with
the recruitment of the 26S proteasome on the mitochondrial surface. Internally, the mitochondrial unfolded protein response (UPRmt) is a quality control system
formed by molecular chaperones and proteases (D).
E3 ubiquitin ligase, is then able to promote the ubiquitination
of several proteins on the mitochondrial surface that will be
subsequently phosphorylated by PINK1, generating a positive
feedback loop mediated by PINK1 and parkin. The net result is
that damaged mitochondria ends coated by P-UB chains that act
as an ‘‘eat-me’’ signal for the mitophagy receptors.
In this model, PINK1 is essential for the phosphorylation of
UB and parkin (both at ser 65), while Parkin has an amplifier
role, enhancing the presence of the molecular signaling for
mitophagy (P-UB) and contributing to the establishment of
a more abundant and faster P-UB chain and consequently a
stronger mitophagic process.
Recent work by Szargel et al. (2016) showed that, in the
absence of Parkin, other E3 UB ligases such as SIAH-1 could
catalyze the polyubiquitination of OMM proteins. PINK1 is still
necessary for the phosphorylation of UB, however, suggesting
that although the P-UB chains on the mitochondrial surface are
the signal for mitophagy receptors, parkin is not essential for this
process (Szargel et al., 2016).
Parkin can form different types of polyubiquitin chains
on different types of OMM substrates. The K48-linked UB
chains are the principal signal for UPS degradation, as will be
mentioned below, but Parkin can also polyubiquitinate OMM
substrates with K63-linked chains; this label is predominantly
a tag for autophagy and recognized by different autophagy
receptors by means of the UBD domain (Akutsu et al., 2016;
Yamano et al., 2016). To date, five different autophagy receptors
(p62, NBR1, Optineurin (OPTN), NDP52 and TAX1BP1) are
able to recognize polyubiquitinated signals in PINK1/parkin-
mediated mitophagy. One of them, p62, has long been linked
to selective autophagy (not only mitophagy), being one of
the main markers of autophagy substrates and widely used as
a marker of autophagic flux together with LC3-II (Klionsky
et al., 2016). However, in the recent study by Lazarou et al.
(2015) they used different combined knock-outs (KOs) of all
five receptors, it was shown that OPTN and NPD52 are indeed
the primary receptors for PINK1/parkin-mediated mitophagy.
These receptors are recruited to mitochondria by the P-UB signal
mediated by PINK1 (which is essential), and enhanced by Parkin
(which is important to amplify the signal, but not essential;
Lazarou et al., 2015). Accordingly, and as previously proposed,
p62 and NBR1 can participate in mitophagy, but are not essential
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(Narendra et al., 2010). The fact that different receptors can have
redundant roles in mitophagy probably suggests the presence
of different mitophagy machineries that are called into action
depending on the availability of mitophagy receptors for each
physiological condition and cell type.
Once the P-UB chains are present and the receptors recruited,
an additional step can improve the overall efficiency of the
process. TANK binding kinase 1 (TBK1) is a kinase activated
by mitochondrial depolarization; it is recruited by the receptors
to the mitochondria where it is able to phosphorylate both
OPTN and NDP52, thereby enhancing the binding of receptors
to UB conjugates (Heo et al., 2015; Richter et al., 2016).
The receptors, via their LIR motif, recruit LC3 together with
other autophagy machinery members (like ULK1 or Atg9) and
the isolated membrane envelops the mitochondria to form an
autophagosome.
At this point, there is an additional modulating step, the P-UB
chains can be removed by deubiquitinating enzymes (DUBs)
that catalyze the removal of ubiquitin chains from substrates.
Different DUBs like UPS30, UPS35, UPS8 and UPS15 are able
to eliminate the polyubiquitin chains on mitochondria and
modulate mitophagy (Bingol et al., 2014; Cornelissen et al., 2014;
Durcan and Fon, 2015; Wang et al., 2015). Overexpression of
these DUBs can inhibit mitophagy, while siRNA knockdown can
activate mitophagy, opening a new therapeutic opportunity to
pharmacologicaly induce mitophagy with selective inhibitors of
these DUBs.
With the information available at present, we can postulate
that PINK1/Parkin-mediated mitophagy uses P-UB conjugates
as a molecular signal to trigger selective autophagy. PINK1 is
the major player, essential for the phosphorylation of UB, while
Parkin plays an important role by amplifying this signal. Once the
receptors are recruited, TBK1 can also enhance the interaction
between components to achieve a robust mitophagy.
It should be noted that some studies have revealed a role
of the PINK1/parkin machinery in an alternative, mitophagy-
independent mechanism involved in mitochondrial quality
control. Several evidences indicate that PINK1 has mitophagy-
independent alternative functions, for example, in regulating
complex I activity andmaintaining neuronal viability in response
to stress (Voigt et al., 2016). Parkin activity as an E3 Ub
ligase, and its ability to catalyze the polyubiquitination of several
mitochondrial proteins is also involved in different mitophagy-
independent mechanisms (Sarraf et al., 2013). In this context,
numerous reports have linked the role of PINK1 and parkin
in mitochondrial dynamics because MFN1 and MFN2, two
proteins regulating mitochondrial fusion, are polyubiquitinated
in a PINK1/parkin-dependent manner upon mitochondrial
depolarization. This P-UB serves as a signal for UPS degradation,
lower levels of MFN reduce fusion (thus avoiding the fusion
of damaged mitochondria with healthy ones) and favores
mitochondrial fission (Gegg et al., 2010; Poole et al., 2010;
Tanaka et al., 2010; Ziviani et al., 2010; Yoshii et al., 2011).
Additionally, other groups described that PINK1/Parkin can
also modulate the activity of Drp1, the main regulator of
mitochondrial fission (Lutz et al., 2009; Pryde et al., 2016)
altogether it seems that the promotion of mitochondrial
fragmentation might facilitate its elimination of damaged
mitochondria.
PINK1/Parkin may also affect axonal transport by
phosphorylating and polyubiquitinating Miro, a protein
involved in the mitochondrial transport machinery. This labeling
of Miro promotes its degradation by the UPS and consequently
impairs mitochondrial motility. This arrest/immobilization of
damaged mitochondria could prevent their fusion with healthy
mitochondria and facilitate its elimination by mitophagy (Wang
et al., 2011; Liu S. et al., 2012).
Taken together, PINK1/parkin act in unison to sense
mitochondrial depolarization and to label damaged
mitochondria, thereby modulating simultaneously different
aspects of the mitochondrial quality control system, such
as mitochondrial fragmentation, the arrest of mitochondrial
motility, and the degradation of damaged mitochondria by
mitophagy.
As a last model of selective degradation of mitochondria
very recently a new Parkin-dependent pathway for the
degradation of whole mitochondria has been proposed by
Gustafsson’s lab. In this new form of mitophagy, the damaged
mitochondria is recognized in a Parkin-mediated step by
the ESCRT machinery of the Rab5-positive early endosome.
The ESCRT machinery induces invagination of the endosome
membrane, leading to internalization of the mitochondria
in the lumen of the endosome. Following maturation, these
endosomes deliver mitochondria to lysosomes for degradation
(Hammerling et al., 2017). This pathways is similar to the
endosomal microautophagy pathway previously described for
the elimination of cytosolic proteins inside the endosomes
and/or multivesicular bodies (MVB) followed by the delivery to
lysosomes for degradation (Sahu et al., 2011) and future work
is required to understand the role of this endosomal-mediated
mitophagy and the possible redundancy or crosstalk with the
autophagsosome-mediated mitophagy.
OTHER FORMS OF (PARTIAL)
MITOCHONDRIAL DEGRADATION: UPS,
UPRmt AND MDVs
Although mitophagy is the only cellular process that eliminates
whole mitochondria, other mechanisms exist to partially
eliminate portions or components of mitochondria. As
mentioned above, some OMM proteins can be degraded by
the UPS after mitochondrial depolarization. This process can
be mediated by parkin-dependent polyubiquitination (mostly
by K48-linked chains) and recruitment of the 26S proteasome
on the mitochondrial surface. This UPS-dependent degradation
of OMM proteins (including TOM subunits, PINK1, MFN1,
MFN2, VDAC, MIRO and FIS1) precedes mitophagy and is
required for proper completion of the mitophagy process (Chan
et al., 2011) (Figure 2).
Internally, the mitochondria also have the mitochondrial
unfolded protein response (UPRmt), a quality control system
formed by molecular chaperones and proteases that promote
proper protein folding, complex assembly, or elimination within
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the mitochondrial matrix. This stress-response is an early
process that activates the transcription of nuclear-encoded
mitochondrial genes related to mitochondrial proteostasis as an
internal quality control system (Haynes and Ron, 2010).
More recently, a new mechanism involving the partial
elimination of portions of mitochondria was described.
Mitochondrial-derived vesicles (MDVs) can be formed by
budding of the mitochondrial membrane; these vesicles
are formed independently of the mitochondrial fission
machinery and are targeted to lysosomes for degradation in
an autophagosome-independent manner (Soubannier et al.,
2012; Roberts et al., 2016) and has some similarities with
the mecanim previously described in yeast for the partial
degradation of mitochondria (Abeliovich et al., 2013). The
MDVs can be formed under basal conditions, but their
production is induced in response to oxidative stress. Once
again, as part of the global mitochondrial quality control
system, PINK1 and Parkin seem to play a regulatory role in
the formation of the MDV after mitochondrial depolarization.
Some authors proposed that strong depolarization of the
mitochondrial membrane will activate the PINK1/Parkin-
mediated elimination of mitochondria by mitophagy, while
mild mitochondrial damage may promote the PINK1/parkin-
mediated removal of a specific portion of the mitochondria
through MDVs (Shlevkov and Schwarz, 2014). Although the
fate of these vesicles is normally degradation within lysosomes,
some MDVs can also be secreted as exosomes or participate in
the autoimmune system given the presence of mitochondrial
antigens that are presented on major histocompatibility





We have thus far reviewed different types of induced mitophagy
that occur in response to mitochondrial depolarization,
hypoxia or under particular physiological scenarios such as the
maturation of reticulocytes or in fertilized oocytes. However,
what mechanism is involved in basal mitochondrial turnover
in neurons, or in response to mitochondrial dysfunction in
neurons? How do neurons, in their condition as post-mitotic
cells exhibiting a heightened susceptibility to mitochondrial
impairment, manage to selectively eliminate these organelles?
Almost all studies on PINK1/Parkin-dependent mitophagy
have been performed on non-neuronal cells, with overexpressed
levels of Parkin, and where mitophagy has been induced with the
uncoupler CCCP, which induces a rapid and massive loss of the
mitochondrial membrane potential in the entire mitochondrial
pool. Such conditions (non-neuronal cells, overexpressed Parkin
and prolonged CCCP treatment) are not physiological and
consequently might not reflect the type of mitophagy occurring
in neurons under basal conditions (Grenier et al., 2013).
To this end, different authors have pointed out that neuronal
mitophagymight follow a PINK1/parkin-alternative mechanism,
principally because the translocation of endogenous Parkin
to mitochondria upon depolarization is controversial. Using
the methodology typically employed with non-neuronal cells,
most groups cannot detect the recruitment of endogenous
parkin to mitochondria in neuronal cell lines (Sterky et al.,
2011; Van Laar et al., 2011; Cai et al., 2012; Rakovic et al.,
2013). Only after the artificially overexpression of parkin,
the protein is translocated to mitochondria, activated and
mitophagy takes place, however, even under such conditions,
the mitophagy process is much slower compared to that seen
in non-neuronal cell lines (Cai et al., 2012; Rakovic et al.,
2013). Other groups also noted that neurons have a different
bioenergetic metabolism and a heavy dependence on oxidative
phosphorylation for the production of ATP (compared to the
more glycolytic metabolism seen in non-neuronal cells), which
might be responsible for the different response of neurons to
CCCP and their inability to recruit parkin (Van Laar et al.,
2011).
It is known that that mitochondrial turnover is active in
neurons (and essential for their survival), meaning that theymust
somehow manage to eliminate old or damaged mitochondria. In
fact, neuronal mitophagy can be measured by quantifying the
colocalization of mitochondrial markers with autophagosomes,
or lysosomal markers by microscopy analysis (Chu et al., 2013;
Klionsky et al., 2016). Neuronal mitophagy can also be quantified
by measuring mitochondrial mass in the presence of lysosomal
inhibitors; when lysosomal degradation is blocked, an increase of
the mitochondrial signal can be detected under basal or induced
conditions, corresponding to altered mitochondrial turnover
(Mauro-Lizcano et al., 2015).
According to the latest model of Parkin/PINK1-dependent
mitophagy, although Parkin might play a role in this pathway,
it is not essential. In the presence of low levels of Parkin
in neurons, induced mitophagy upon strong depolarization
can take place in a PINK1-dependent manner, but the
rate of mitochondrial clearance is slow due to the lack of
parkin’s amplification. In this context, some authors distinguish
between mitochondrial degradation under basal conditions
and that in the presence of mild or severe mitochondrial
depolarization. Some parkinsonian toxins like rotenone or
6-OHDA can induce mild depolarization in neurons (compared
to the strong depolarization with CCCP); such small decreases
in mitochondrial membrane potential are not sufficient to
activate PINK1/parkin-dependent mitophagy in neurons, and no
retention of full length PINK1 or recruitment of parkin can be
detected in the mitochondria. However, it has been observed
that other alternative pathways, such as that of CL-dependent
mitophagy (Chu et al., 2013) can handle the elimination
of moderately dysfunctional mitochondria. Alternatively, mild
dysfunctional mitochondria could also be eliminated partially
by MDV as mentioned above. In summary, neurons can
eliminate dysfunctional mitochondria, which is essential for their
survival, but different mechanisms might be activated in line
with the severity of mitochondrial damage and the cell type
involved. In this way, themost well-characterized PINK1/parkin-
dependent pathway might be activated in response to severe
mitochondrial damage, but this would probably only occur
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Parkinson’s disease (PD) is the second most common ND after
Alzheimer’s disease (AD) and the most common movement
disorder. The main risk factor for developing PD is age, affecting
about 2% of the population over 60 years. Clinically, PD
is characterized by bradykinesia, resting tremor, rigidity and
postural instability. At the molecular level, these symptoms are
caused by a loss of dopaminergic neurons in the substantia
nigra pars compacta (SNpc) and a resulting decrease of
dopamine (DA) levels in the striatum. In addition, the disease
is characterized by the presence within affected neurons of
cytoplasmic protein inclusions called Lewy bodies (LBs), which
have alpha-synuclein protein as their main component (Dauer
and Przedborski, 2003). Today, despite great advances in
biomedical research, only symptomatic treatments are available
that relieve many of the motor symptoms of the disease, without
stopping or slowing down the progressive death of neurons.
Althoughmost PD patients are diagnosed as sporadic patients
with idiopathic PD, other less common forms of familial PD have
facilitated the identification of different autosomal recessive and
autosomal dominant genes linked to PD, as well as different gene
variants identified as PD risk factors (Klein and Westenberger,
2015). Among the monogenic forms of PD, two genes causing
autosomal recessive forms of the disease are PARK2 and PARK6,
which encode Parkin and PINK1, respectively, and as we have
seen above are the main players in PINK1/parkin-mediated
mitophagy. The fact that mutations in these two genes are linked
to autosomal recessive forms of PD led to greater attention
being focused on mitophagy, and the possibility that impaired
mitochondrial turnover might be one of the main contributors
to PD pathogenesis.
The clinical phenotypes of Parkin- and PINK1-linked PD
are indistinguishable from sporadic PD, although the former
show an earlier disease onset, particularly in the case of mutated
Parkin, which is the most frequent cause of juvenile PD
(Matsumine et al., 1997). At the neuropathological level, no
apparent differences exist between Parkin- and PINK1-linked PD
with sporadic PD in terms of dopaminergic neuronal loss, gliosis
and LB load.
Several PINK1-KO and parkin-KO mouse models have
been developed in recent years by different groups; however
most of them do not recapitulate the PD phenotype. Most of
these animal models do not show neuronal loss, altered DA
metabolism, presence of LBs, or abnormalities in motor behavior
(Blesa and Przedborski, 2014). These PINK1- and parkin-KO
mice, however, exhibit a clear mitochondrial dysfunction, but
probably not enough to trigger neuronal death. Only some
particular mouse models developed by some groups exhibit a
slight impairment of DA release (Itier et al., 2003; Kitada et al.,
2009) and some knock-in mutant Parkin mice present some
minor motor deficits and neuronal loss (Sriram et al., 2005; Van
Rompuy et al., 2014). In contrast, parkin- and PINK1-mutant fly
models have shown a more clear-cut PD phenotype, including
mitochondrial dysfunction as well as dopaminergic neuronal
loss, significant motor disabilities and reduced lifespan (Greene
et al., 2003; Pesah et al., 2004; Clark et al., 2006; Yang et al., 2006;
Burman et al., 2012).
These results again suggest that PINK1 and parkin play
important roles in the mitochondrial quality control system of
neurons, including but not limited to mitophagy. Due to the
particular vulnerability of neurons to mitochondrial impairment,
any alteration of themitochondrial homeostasismight contribute
the pathogenesis of PD. In the mouse models, damage to the
mitochondria might not be sufficient to affect neuronal viability,
or other processes might compensate for the PINK1/parkin loss.
In humans, however, the occurrence of mutations in these genes
might be enough to trigger PD.
Alzheimer’s Disease
AD is the most common neurodegenerative disorder, resulting
in severe memory loss and cognitive dysfunction. The principal
pathological hallmarks of AD are intracellular neurofibrillary
tangles (NFTs), mostly constituted by hyperphosphorylated Tau
protein, and extracellular senile plaques containing amyloid-β
peptide (Aβ), derived from proteolytic processing of amyloid
precursor protein (APP; Ittner and Götz, 2011).
Increasing evidence shows that, in the etiology of AD,
different processes contribute to neurodegeneration, including
mitochondrial dysfunction, oxidative stress and impairment
of the autophagic/lysosomal/endosomal system. Numerous
studies have shown that alterations in mitochondrial dynamics,
morphology, motility and activity are linked to AD, and together
with oxidative stress seem to be important early events in this
disease (Nunomura et al., 2001; Moreira et al., 2010; Cai and
Tammineni, 2016).
On the other hand, work done by Nixon’s group and others
have shown that the lysosomal network, including the two
pathways that deliver material to the lysosome (autophagy and
the endosomal system), are affected in AD. Ultrastructural
analyses of AD brains have revealed that affected neurons
exhibit abnormally enlarged endosomes, depleted lysosomes,
and accumulation of autophagosomes loaded with undigested
material that cannot be cleared by lysosomes (Nixon et al., 2000,
2005; Nixon and Yang, 2011; Ihara et al., 2012).
The formation of extracellular senile plaques containing Aβ
starts with the processing of APP by β- and γ-secretases; some
of the resulting Aβ peptides can spontaneously aggregate to
form oligomers and subsequently insoluble fibrils in a process
called amyloidogenesis (LaFerla et al., 2007). These oligomeric
Aβ are the precursors of the insoluble amyloid fibrils and are
considered responsible for the neurotoxicity present in AD.
This amyloidogenic processing can occur both externally at the
plasma membrane, where APP localizes, as well as inside the
cell, in the membranes of different cellular compartments where
the APP along with the β- and γ-secretases are also present.
These intracellular compartments include endosomes, the trans-
Golgi network (TGN), the ER, lysosomes, autophagosomes,
MVB and mitochondria (Walsh et al., 2002). Thus, Aβ can
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be found both extracellularly and intracellularly where it can
interfere with different cellular pathways. The endosomal system
participates at different levels in the production of Aβ. These
include the processing of APP toAβ at the endosomalmembrane,
the internalization of external Aβ by endocytosis, and in the
intracellular trafficking and secretion of Aβ to the outside of the
cell. Changes in the endosomal system have been observed in AD,
and several proteins regulating this pathway shown to be altered
and thereby affecting the regulation, sorting, trafficking and
secretion of endosomal vesicles. As a result, levels of intracellular
Aβ increase and promote further endosomal dysfunction as a
consequence (Peric and Annaert, 2015).
The acidification of lysosomes can be compromised when
PS-1 (which causes early-onset familial AD) is mutated or absent,
because the processing of the subunits of the lysosomal pump
is affected. As a result, lysosomal proteolysis is impaired and
lysosomes cannot degrade the material loaded by endosomes
or autophagosomes (Lee et al., 2010). Lysosome stability can
also be affected by the presence of the lipoprotein ApoE4
(whose gene mutation is the main genetic risk factor for
AD) and Aβ, both of which can bind to and destabilize
the lysosomal membrane and lead to lysosomal membrane
permeabilization (Ji et al., 2006). As a compensatory response,
several genes promoting autophagy are up-regulated at the
transcriptional level (Lipinski et al., 2010); however, ultimately,
there is an accumulation of abnormal endosomes and overloaded
autophagosomes.
In summary, AD-associated dysfunction is linked to the
endosomal pathway, lysosomal integrity and the autophagic
pathway, all of which are inter-related and -dependent. However,
although selective autophagy (and intrinsically, mitophagy)
might be affected in AD, very little has been studied on this
topic, and only a few reports have focused on the role of
mitophagy in AD (Khandelwal et al., 2011; Wang et al., 2016).
Since mitochondrial dysfunction is a hallmark of AD, and
neuronal autophagy is also dysfunctional in affected neurons, we
suggest that mitophagy might also be impaired. It remains to be
determined if the presence of dysfunctional mitochondria is a
consequence of inefficient mitophagy, or whether mitochondrial
dysfunction is an early event preceding impairment of the
autophagy/mitophagy systems.
Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis (ALS) is a fatal disease
characterized by the selective degeneration of motor neurons.
A hallmark of the disease, as in other ND, is the accumulation
of aggregated proteins within affected neurons. Most ALS
cases are sporadic (SALS), with only about 10% classified
as familial forms of ALS (FALS). Genetic studies of these
familial cases has permitted the identification of several
genes linked to ALS (Cirulli et al., 2015). Among these are
several genes related to cellular quality control pathways,
and more specifically to selective autophagy and mitophagy.
These include genes encoding the mitophagy receptors OPTN
and p62 (or SQSTM1), as well as TBK1, which activates
mitophagy receptors via phosphorylation. In vitro, different
ALS-linked mutations in genes encoding these proteins
can affect selective autophagy. In this way, mutant OPTN
and TBK1 can interfere with the process of mitophagy,
while mutant p62, which shows a lower affinity for LC3-II,
reduces the efficiency of selective autophagy (Maruyama
et al., 2010; Wong and Holzbaur, 2014; Majcher et al.,
2015; Moore and Holzbaur, 2016). These data suggest
that the inefficient turnover of damaged mitochondria
and also aggregates, may contribute to neurodegeneration
in ALS.
Frontotemporal dementia (FTD) is an ND affecting
cortical neurons and the basal ganglia, resulting in cognitive
impairment, language deficiency and changes in social
behavior and conduct. Despite the differences in the
types of neurons affected, and consequently in the clinical
symptoms manifested in ALS and FTD, both diseases show
significant clinical and genetic overlap (Weishaupt et al.,
2016), with up to 50% of patients with ALS developing
FTD symptoms and approximately 15% of FTD patients
displaying motoneuron dysfunction typical of that seen in
ALS (Lomen-Hoerth et al., 2002). Some of the genes linked
to ALS were also found to be related to FTD, among which
are those related to mitophagy/selective autophagy: OPTN,
TBK1 and p62. The molecular mechanisms underlying which
neurodegenerative disorder (ALS, FTD or ALS/FTD) is
manifested in the presence of mutations in these genes remain
unknown.
Huntington’s Disease
Huntington’s disease (HD) is an autosomal-dominant
neurodegenerative disorder caused by an expansion of the
cytosine-adenine-guanine (CAG) trinucleotide repeat encoding
a polyglutamine (polyQ) tract in the amino-terminal region
of Huntingtin (Htt) protein. Clinically, HD is characterized
by motor dysfunction, cognitive decline and psychiatric
disturbances caused by the preferential atrophy of GABAergic
medium spiny neurons in the striatum as well as in other regions
such as the cerebral cortex (Ross and Tabrizi, 2011).
The expansion of more than 37 CAG repeats within
the huntingtin gene generates an aberrant, misfolded protein
(mutant Htt or mHtt) that is prone to form aggregates in the
affected neuron (Sapp et al., 1997). Htt is a huge protein that
can interact with numerous other proteins (Li and Li, 2004;
Kaltenbach et al., 2007; Culver et al., 2012), meaning thatmultiple
biological functions can be affected in the presence of mHTT.
Several physiological mechanisms have been implicated in the
HD pathogenesis, however the complete etiology of this disease
remains unclear.
Amongmany cellular mechanisms, mHTT has been proposed
to affect transcriptional regulation, synaptic transmission,
axonal trafficking, nuclear export/import, ubiquitin-mediated
proteolysis and regulation of the endosomal/autophagic system
(Pal et al., 2006; Martinez-Vicente et al., 2010; Caviston et al.,
2011; Koga et al., 2011; Costa and Scorrano, 2012; Gouarné et al.,
2013; Guedes-Dias et al., 2016). As in other ND, mitochondrial
dysfunction and proteostasis alterations, particularly in the
autophagic/endosomal system, are linked to the pathogenesis of
HD (Ross and Tabrizi, 2011).
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The role of mHTT in the pathogenesis of the
autophagic/lysosomal/endosomal system has been described
at multiple molecular steps; in the initiation of the autophagic
process, mHtt can affect the expression at the transcriptional
level of different autophagy-related genes (Metzger et al., 2013).
At the cargo recognition step in selective autophagy, the Htt
protein plays an important role as a scaffolding protein in the
stabilization of the different protein complexes involved. The
presence of the polyQ tract can affect the efficiency of this
step and consequently the clearance of damaged mitochondria
by mitophagy (Martinez-Vicente et al., 2010; Ochaba et al.,
2014; Rui et al., 2015). Htt protein can also interact with motor
proteins like dynein and kinesin, thus playing an important
function in the microtubule-dependent transport of endosomes,
autophagosomes and lysosomes. The presence of mHtt can
affect the efficiency of all the pathways that strongly depend
on vesicular trafficking like autophagy and endocytosis to
which we should also add the effect of mHtt on different Rab
proteins, the regulators of the endocytic trafficking (Caviston
and Holzbaur, 2006; Caviston et al., 2007, 2011; Ravikumar et al.,
2008).
Beyond HD, there are other polyQ diseases characterized by
the pathological expansion of CAG trinucleotide repeat. Despite
the fact that in each polyQ disorder a different protein carries the
polyQ tract, all these disorders present some common molecular
mechanisms related to the pathology like the aggregation of
the mutant protein, alterations of the protein quality control
including autophagy and mitochondrial dysfunction (Weber
et al., 2014).
CONCLUSION
Since 2006 it has been well established that a lack of basal
autophagy in neurons, including all types of selective
macroautophagy such as mitophagy, is enough to produce
neuronal death (Hara et al., 2006; Komatsu et al., 2006).
The neuronal-specific Atg5-KO and Atg7-KO mouse
models demonstrated that if neurons in the central nervous
system cannot properly turnover proteins and organelles
like mitochondria the consequence is the accumulation of
polyubiquitinated substrates and inclusion bodies, resulting in
cell death. Thus mitophagy is essential for neurons, under basal
conditions and after mitochondrial damage, and neurons seem
to be able to eliminate partially or completely mitochondria
through the action of different mechanisms. Whether these
mechanisms are coordinated or redundant, or whether they are
activated in response to different conditions is an issue that stills
requires future investigations, but undoubtedly dysfunctional
mitophagy in neurons might have important implication in
neurodegeneration.
Regarding PINK1/parkin-mediated mitophagy role in
neurons, we must consider this pathway as one of the possible
mitophagy pathways used by neurons to eliminate mitochondria
after a strong depolarization, however, we must be aware that
the participation of endogenous Parkin in neuronal mitophagy
might not be such essential as the observed in artificial cellular
models. However, we should have a boarder view of PINK1 and
Parkin as mitochondrial stress sensors and key components of
the global mitochondrial quality control system and not only in
mitophagy.
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